{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:46:58Z","timestamp":1768546018094,"version":"3.49.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"Supplement_E","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pulmonary vein isolation is the standard for atrial fibrillation ablation. Although the most commonly applied energy source is radiofrequency (RF), cryoablation has rapidly evolved as a powerful one-shot tool, particularly after the introduction of the second-generation catheter, gaining widespread use in recent years. The efficacy in maintaining sinus rhythm after a first ablative procedure is \u223c70\u201380%, and the randomization studies comparing cryoablation to RF have not been able to reveal significant differences up to now. Although different baseline characteristics may influence the efficacy of cryoablation, we are not yet able to distinguish which patients may benefit from a personalized choice of ablative source. Regarding safety, cryoballoon ablation appears to be associated with a lower rate of pericardial effusion and cardiac tamponade, mainly due to the lack of risk of overheating. The other side of the coin is a higher incidence of phrenic nerve damage, which occurs in 1\u20132% of procedures. In conclusion, we do not yet have definitive data to affirm the superiority of the RF technique over that of cryoablation. The choice of energy source currently depends on the availability of the centre and on the experience of the operator.<\/jats:p>","DOI":"10.1093\/eurheartj\/suab089","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T09:40:00Z","timestamp":1633945200000},"page":"E51-E54","source":"Crossref","is-referenced-by-count":7,"title":["How effective is cryoablation in the treatment of atrial fibrillation?"],"prefix":"10.1093","volume":"23","author":[{"given":"Diego","family":"Penela","sequence":"first","affiliation":[{"name":"Centro di Aritmologia Clinica ed Elettrofisiologia, IRCCS Multimedica Group, Sesto San Giovanni, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Cappato","sequence":"additional","affiliation":[{"name":"Centro di Aritmologia Clinica ed Elettrofisiologia, IRCCS Multimedica Group, Sesto San Giovanni, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"2021101106041962400_suab089-B1","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/01.CIR.102.20.2463","article-title":"Electrophysiological breakthroughs from the left atrium to the pulmonary veins","volume":"102","author":"Ha\u00efssaguerre","year":"2000","journal-title":"Circulation"},{"key":"2021101106041962400_suab089-B2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.CIR.100.11.1203","article-title":"Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system","volume":"100","author":"Pappone","year":"1999","journal-title":"Circulation"},{"key":"2021101106041962400_suab089-B3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005053-196109000-00013","article-title":"Cryostatic congelation: a system for producing a limited controlled region of cooling freezing of biologic tissues","volume":"133","author":"Cooper","year":"1961","journal-title":"J Nerv Ment Dis"},{"key":"2021101106041962400_suab089-B4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1046\/j.1540-8167.2002.01082.x","article-title":"Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia)","volume":"13","author":"Rodriguez","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021101106041962400_suab089-B5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/europace\/euaa236","article-title":"Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) Registry","volume":"23","author":"Vassilikos","year":"2021","journal-title":"Europace"},{"key":"2021101106041962400_suab089-B6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0735-1097(03)00788-5","article-title":"Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis","volume":"42","author":"Tse","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2021101106041962400_suab089-B7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pace.12787","article-title":"One-year clinical outcome of pulmonary vein isolation using the second-generation cryoballoon: a meta-analysis","volume":"39","author":"He","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"2021101106041962400_suab089-B8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10840-015-0075-4","article-title":"Safety and efficacy of second-generation versus first-generation cryoballoons for treatment of atrial fibrillation: a meta-analysis of current evidence","volume":"45","author":"Pandya","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"key":"2021101106041962400_suab089-B9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/europace\/euaa406","article-title":"Optimizing cryoballoon pulmonary vein isolation: lessons from &gt;1000 procedures\u2014the Frankfurt approach","volume":"23","author":"Bordignon","year":"2021","journal-title":"Europace"},{"key":"2021101106041962400_suab089-B10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","article-title":"Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial","volume":"140","author":"Andrade","year":"2019","journal-title":"Circulation"},{"key":"2021101106041962400_suab089-B11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"2021101106041962400_suab089-B12","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"2021101106041962400_suab089-B13","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehw285","article-title":". Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial","volume":"37","author":"Kuck","year":"2016","journal-title":"Eur Heart J"},{"key":"2021101106041962400_suab089-B14","doi-asserted-by":"crossref","first-page":"e007247","DOI":"10.1161\/CIRCEP.119.007247","article-title":"Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE AND ICE trial","volume":"12","author":"Kuck","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2021101106041962400_suab089-B15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/europace\/euy239","article-title":"Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry","volume":"21","author":"M\u00f6rtsell","year":"2019","journal-title":"Europace"},{"key":"2021101106041962400_suab089-B16","doi-asserted-by":"crossref","first-page":"e006043","DOI":"10.1161\/JAHA.117.006043","article-title":"The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: an economic analysis from the FIRE AND ICE trial","volume":"6","author":"Chun","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2021101106041962400_suab089-B17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/europace\/euw330","article-title":"Cryoablation vs. radiofrequency ablation for treatment of paroxysmal atrial fibrillation: a systematic review and meta-analysis","volume":"19","author":"Chen","year":"2017","journal-title":"Europace"},{"key":"2021101106041962400_suab089-B18","first-page":"48","article-title":"Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible?","volume":"19","author":"Providencia","year":"2017","journal-title":"Europace"},{"key":"2021101106041962400_suab089-B19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/europace\/euz155","article-title":"Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation","volume":"21","author":"Hoffmann","year":"2019","journal-title":"Europace"},{"key":"2021101106041962400_suab089-B20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.hrthm.2017.05.003","article-title":"Acute efficacy, safety, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with a left common pulmonary vein: a multicenter study","volume":"14","author":"Heeger","year":"2017","journal-title":"Heart Rhythm"},{"key":"2021101106041962400_suab089-B21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.hrthm.2017.06.019","article-title":"Second-generation cryoballoon ablation in the setting of left common pulmonary veins: procedural findings and clinical outcome","volume":"14","author":"Str\u00f6ker","year":"2017","journal-title":"Heart Rhythm"},{"key":"2021101106041962400_suab089-B22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.hrthm.2020.04.020","article-title":"Sex-specific efficacy and safety of cryoballoon versus radiofrequency ablation for atrial fibrillation: An individual patient data meta-analysis","volume":"17","author":"Du Fay de Lavallaz","year":"2020","journal-title":"Heart Rhythm"},{"key":"2021101106041962400_suab089-B23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacep.2020.08.016","article-title":"Concomitant pulmonary vein and posterior wall isolation using cryoballoon with adjunct radiofrequency in persistent atrial fibrillation","volume":"7","author":"Aryana","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2021101106041962400_suab089-B24","doi-asserted-by":"crossref","first-page":"f436","DOI":"10.1093\/europace\/eux295","article-title":"PLAAF score as a novel predictor of long-term outcome after second-generation cryoballoon pulmonary vein isolation","volume":"20","author":"Akkaya","year":"2018","journal-title":"Europace"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/23\/Supplement_E\/E51\/40544785\/suab089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/23\/Supplement_E\/E51\/40544785\/suab089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T09:40:34Z","timestamp":1633945234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/23\/Supplement_E\/E51\/6386360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":24,"journal-issue":{"issue":"Supplement_E","published-online":{"date-parts":[[2021,10,8]]},"published-print":{"date-parts":[[2021,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suab089","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,10,1]]}}}